NCT05142163

Brief Summary

Patients were allotted to two Groups , SVV Guided Fluid Therapy Group received intraoperative fluids to maintain SVV \<11 , and PVI Guided Group received intraoperative Fluids to maintain PVI\<11

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 6, 2021

Completed
2 days until next milestone

Study Start

First participant enrolled

November 8, 2021

Completed
24 days until next milestone

First Posted

Study publicly available on registry

December 2, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2022

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2022

Completed
Last Updated

March 5, 2024

Status Verified

March 1, 2024

Enrollment Period

7 months

First QC Date

November 6, 2021

Last Update Submit

March 3, 2024

Conditions

Keywords

Goal directed Fluid TherapyStroke Volume VariationPlethysmography

Outcome Measures

Primary Outcomes (1)

  • To compare Total intraoperative Fluid requirement in millilitres and Fluid Responsiveness in SVV and PVI Group.

    Patients in SVV Group will receive Crystalloids and colloid bolus 200ml to maintain SVV \<11 .Patients in PVI Group will receive Crystalloids and colloid bolus to maintain PVI\<11, Postbolus response to SVV and PVI values will be noted.

    upto 8 hours

Secondary Outcomes (5)

  • To Measure Serum Lactate levels mmol/L in SVV and PVI Group.

    upto 72 hours postoperative

  • Postoperative Cardiac complication

    upto72 hours

  • Postoperative Respiratory complication

    upto 72 hours

  • Postoperative Renal complication

    upto72 hours

  • Length of ICU stay

    upto72 hours

Study Arms (2)

Stroke Volume Variation Guided Fluid Therapy

ACTIVE COMPARATOR

Patients will receive maintenance Fluids as crystalloids intraoperative to maintain SVV \<11%, for values \>11%colloid bolus 6%hydroxyethyl starch will be given and fluid responsiveness noted.

Other: Intraoperative SVV Guided Fluid Therapy

Plethysmography Variability Index Guided Fluid Therapy

ACTIVE COMPARATOR

Patients will receive maintenance Fluids as crystalloids intraoperative to maintain PVI \<11%, for values \>11%colloid bolus 6%hydroxyethyl starch will be given and fluid responsiveness noted.

Other: Intraoperative PVI Guided Fluid Therapy

Interventions

Patients will receive intraoperative maintenance Fluids as crystalloids to maintain SVV \<11%, for values \>11%colloid bolus 6%hydroxyethyl starch will be given and fluid responsiveness noted.

Stroke Volume Variation Guided Fluid Therapy

Patients will receive intraoperative maintenance Fluids as crystalloids to maintain PVI \<10%, for values \>10%colloid bolus 6%hydroxyethyl starch will be given and fluid responsiveness noted.

Plethysmography Variability Index Guided Fluid Therapy

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing Open major Oncosurgeries under General Anaesthesia

You may not qualify if:

  • Patient Refusal
  • Left ventricular Ejection Fraction \<40%
  • Cardiac arrythmias
  • Severe valvular heart disease
  • Peripheral Vascular Disease
  • Laparoscopic surgeries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rajiv Gandhi Cancer Institute and Research Centre

Delhi, 110085, India

Location

Study Officials

  • Anita Kulkarni, MD

    Senior Consultant

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patient were masked about belonging to SVV Guided or PVI Guided Group to receive Intraoperative Fluid Therapy
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Patients were allotted to either SVV Guided or PVI Guided Intraoperative Fluid Therapy
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Consultant

Study Record Dates

First Submitted

November 6, 2021

First Posted

December 2, 2021

Study Start

November 8, 2021

Primary Completion

June 10, 2022

Study Completion

June 15, 2022

Last Updated

March 5, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations